A psoriatic patient with absolute deficiency of IgA is reported. The manifesta tions of poriasis appeared at the age of 6 months and proved to be resistant to various treatments. The present case report and the data available in the literature on IgA and psoriasis all converge on the hypothesis that IgA is a systemic factor which belongs to the 'off switches' of the psoriatic process.
Inflammation, epidermal proliferation and abnormal dif ferentiation of the epiderm is are the well-known abnormali ties in the pathogenesis of psoriasis. The immunology of psoriasis has been reviewed recently [1] . One part of the immunology in psoriasis regards the 'noncellular compo nents'. An important observation, highlighting the rele vance of non-cellular systemic factors in psoriasis is the fact that serum from patients with stable psoriasis repressed the Kobner reaction, whereas serum derived from patients with unstable relapsing psoriasis failed to suppress this phenom enon [2] . This observation may indicate that serum factors in chronic stable psoriasis have an antipsoriatic potential, protecting the patient against progression.
Functionally, serum factors may modulate chemotaxis of m onocytes and neutrophils and may interfere with angioneogenesis and proliferation o f fibroblasts [3 -6 ] . Non-cel lular systemic factors which m ight be involved in the imm unopathogenesis o f psoriasis are numerous. It has been suggested that IgA and IgA immune complexes are in volved in the pathogenesis o f psoriasis [7 -9 ] .
Recently, we had the opportunity to treat a patient with a com plete deficiency o f IgA who had psoriasis of the chronic plaque type with an unusual course: initiation of psoriasis was at the age of 6 months, and the course was resistant to various treatments. The patient was admitted to the inpatient department for treatment with dithranol paste. However, due to irritation, already at low concentrations, the treatment had to be changed to a short-contact schedule with dithranol creams, tar preparations, corticosteroids, hydrocolloid dressing and UVB phototherapy. Due to insufficient improvement, additional treatment with acitretin (3 5 -5 0 mg/day) was given. Following a 10-week admission, the intensified combined treatments had resulted in a considerable improvement, although total clearing was not reached.
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groups is the correlation betw een increased serum levels of IgA and the extent of the skin m anifestations and severity of arthritis [18, 25] , H ow ever, it has been reported that pso riasis with arthropathy m ay coexist with a selective IgA deficiency [26] , Two groups have reported on decreased IgA levels in psoriatic patients [27, 28] , The correlation between disease activity and IgA levels [18, 25] suggests that IgA is o f significance in the pathogenesis of psoriasis. It is attractive to hypothesize that IgA is an 'antipsoriatic factor'. Indeed, relatively high levels o f IgA have been m easured in chronic long-standing plaque psoriasis and in patients with extensive lesions, in contrast to the low levels of IgA in relapsing and guttate-type psoriasis [18] . Patients with decreased or undetectable IgA levels and psoriasis [2 6 -2 8 ] m ay have an unfavorable prognosis according to The accumulation of T lymphocytes and polymorphonu-this hypothesis clear leukocytes and the abnormal functioning of these cells
The present case report is in line with a protective role of are thought to be relevant and crucial aspects of the patho-IgA with respect to the relapse of psoriasis. The unusual genesis of psoriasis [1, 10], Both cell types have been course -onset at the age of 6 m onths and the unstable feareported to possess receptors for the Fc portion of the IgA tures, characterized by extrem e dithranol sensitivity and molecule [11] [12] [13] [14] , With respect to functioning of the poly-therapy resistance -in a patient w ith IgA deficiency m ay morphonuclear leukocyte, it has been shown that IgA para-suggest that IgA indeed belongs to the 'o ff sw itches' o f the proteins and polymeric forms of IgA inhibit the chemotaxis psoriatic process. H ow ever, it is rem otely possible that the and the bactericidal activity of these cells [15] [16] [17] . Schro-episodes of recurrent infections m ight have been respon der et al. [18] reported on the neutrophil chemotaxis inhi-sible for the onset of psoriasis in early childhood, biting activity o f sera from patients with psoriasis and other neutrophilic dermatoses. The inhibition of chemotaxis proved to correlate with increases in serum IgA. Patients with chronic stationary psoriasis showed high IgA levels and reduced neutrophil chemotactic activity whereas those patients with relapsing psoriasis had normal IgA levels and increased neutrophil chemotactic activity [18] . This obser vation lends support for the supposition that an increase in serum IgA might be an antipsoriatic mechanism, stabilizing the psoriatic process. However, although neutrophil chem o taxis inhibiting activity of sera from patients with psoriasis has been shown to depend upon IgA polymeric forms in vitro, it is not clear whether this is im portant in vivo [19] .
Different groups have reported that serum IgA levels are increased in psoriasis [8, 2 0 -2 4 ]. Circulating IgA immune complexes have also been reported to be increased in psori asis [9, 25] . Guilhou et al. [8] reported that the increase in IgA is specific for psoriasis as no patient with eczema had such an increase. By these authors, the increase in IgA-containing immune complexes was observed in 67% of a group of psoriatics whereas a similar increase was found in only 1 out of 25 patients with hyperkeratotic disorders. Fraser et al [20] reported increased levels of IgA in patients with dermatitis herpetiformis, acne vulgaris, rosacea and discoid lupus erythematosus. A consistent observation by various
